The additional study results were presented in an oral presentation session at the 2025 San Antonio Breast Cancer Symposium (“SABCS”) today, Thursday, ...
News
- Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase ... - StreetInsider
- ADC Post-Endocrine Therapy Misses Mark in Advanced Breast Cancer Trial
SAN ANTONIO -- The antibody-drug conjugate (ADC) sacituzumab govitecan ... Biotechnology. Lathrop had no relevant financial disclosures ...
- Wobble Genomics To Present New Data At SABCS Confirming Platform's Ability To ... - Morningstar
EDINBURGH, Scotland, Dec. 11, 2025 /PRNewswire/ -- Wobble Genomics, a biotechnology ... San Antonio, Texas. The data demonstrates the ability to ...
- Avenzo Therapeutics Presents Initial Results from the Phase 1/2 Study of AVZO-021, a ...
... San Antonio Breast Cancer Symposium. Share. SAN DIEGO, Calif.--(BUSINESS WIRE)--Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology ...
- Preoperative radiation may improve antitumor immune response in most common form of ...
Biomedical technology · Cardiology · Dentistry · Diabetes · Diseases ... San Antonio Breast Cancer Symposium (SABCS), held December 9–12, 2025 ...